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Abstract 
Background: Somatosensory stimulation (SS) is a potential adjuvant to stroke rehabilitation, 
but the effect on function needs further investigation.  
Objective: To explore the effect of combining SS with task specific training (TST) on upper 
limb function and arm use in chronic stroke survivors and determine underlying mechanisms. 
Methods: In this double-blinded randomised controlled trial (ISRCTN 05542931), 33 
patients (mean 37.7 months post-stroke) were block randomised to two groups: active or 
sham SS. They received 12 sessions of 2 hours of SS (active or sham) to all three upper limb 
nerves immediately before 30 minutes of TST. The primary outcome was the Action 
Research Arm Test (ARAT) score. Secondary outcomes were time to perform the ARAT, 
Fugl-Meyer Assessment score (FM), Motor Activity Log (MAL) and Goal Attainment Scale 
(GAS). Underlying mechanisms were explored using transcranial magnetic stimulation 
(TMS) stimulus-response curves and intracortical inhibition. Outcomes were assessed at 
baseline, immediately following the intervention (mean 2 days), 3 and 6 months (mean 96 & 
190 days). 
Results: The active group (n= 16) demonstrated greater improvement in ARAT score and 
time immediately post-intervention (between-group difference; p< 0.05), but not at 3 or 6 
month follow ups (p> 0.2). Within-group improvements were seen for ARAT, GAS and 
MAL (p< 0.05), but there were no FM or TMS changes. 
Conclusions: Long lasting improvements in upper limb function were observed following 
TST. Additional benefit of SS was seen immediately post treatment, but did not persist and 
the underlying mechanisms remain unclear.  
 
Keywords: Stroke, Somatosensory Stimulation, Upper Limb, Task Specific Training, 
Rehabilitation, Transcranial Magnetic Stimulation 
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Introduction 
Stroke is a leading cause of long term adult disability1. Despite rehabilitation only 38% of 
people recover some dexterity by six months2 and the majority have persistent disability3.  
Recovery could be facilitated by adjuvant strategies which facilitate brain plasticity4. 
 
Somatosensory stimulation (SS) involves low intensity electrical stimulation of peripheral 
nerves, inducing paraesthesia without substantial motor output. Corticospinal excitability 
increases beyond the stimulation period in healthy adults5-7. In chronic stroke survivors, 
improvements in pinch strength8, functional task performance9 and motor training10,11 have 
been observed after a single session. Several studies have examined the cumulative effect of 
SS and motor training in chronic stroke12-14. McDonnell et al.13 found small improvements in 
hand dexterity, which were not accompanied by changes in corticospinal excitability. This 
study had a small sample size and a relatively short intervention (9 sessions) which may have 
limited the effect.  Two studies trialled home-based SS with motor training12,14. Dos Santos-
Fontes et al.12 found improvements in function only for the active stimulation group that 
appeared to persist for at least four months, whereas Sullivan et al.14 found no between-group 
differences. The main difference between the studies lies in the method of SS, as Dos Santos-
Fontes et al. stimulated the median nerve whereas Sullivan et al. used a glove electrode to 
stimulate the hand. Nerve stimulation may be more effective at priming the motor system 
than non-specific hand stimulation. Simultaneously stimulating all of the forearm nerves may 
further improve the effectiveness of SS. 
 
Our aim was to extend understanding of SS effectiveness in chronic stroke by combining 
stimulation of all three forearm nerves with task specific training (TST)15-17. We hypothesised 
that active stimulation would yield greater improvements than sham for functional ability 
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(Action Research Arm Test18), impairment (Fugl-Meyer Assessment Scale19) and arm use 
(Motor Activity Log20) with associated changes in corticospinal excitability (Transcranial 
Magnetic Stimulation). 
 
Methods 
 
Participants 
Thirty three participants (13 women, mean age 61.5 years, range 24-84) with first ever stroke 
≥3 months duration (average 37.7 months, range 3-130) were included (Table 1). Time since 
stroke and stroke location were determined from medical records when possible (Table 1). In 
some cases only limited information regarding stroke location was available. Participants 
were recruited between July 2010-2012 from five National Health Service sites, the South 
London Stroke Register, stroke support groups and informal networks. All appointments 
were conducted in a laboratory at King’s College London. Original inclusion criteria were; 
age >65 years, unilateral upper limb weakness, physically able to participate (including being 
ambulant and able to negotiate a flight of stairs with assistance), completed upper limb 
rehabilitation and the presence of motor evoked potentials (MEPs) in response to 
Transcranial Magnetic Stimulation (TMS) with the muscles at rest or pre-activated21. 
Exclusion criteria were; contraindications to TMS such as epilepsy or seizures, cardiac 
pacemakers or metal implants in the head, severe spasticity (Modified Ashworth Scale22  ≥4), 
dysphasia or cognitive dysfunction sufficient to limit ability to provide informed consent. 
Due to slow recruitment the inclusion criteria were amended after ~8 months to include 
participants 18-65 years, with contraindications to TMS (n= 4, sham) or who declined to have 
TMS (n= 1, active). All participants gave written informed consent and the study was 
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approved by the National Research Ethics committee. The study was registered as a 
randomised clinical trial (RCT); ISRCTN 05542931. 
 
Experimental Design (Fig. 1) 
Randomisation 
In this double-blinded RCT (Fig. 1) block randomisation (up to 6 per group) was performed 
by the physiotherapist using coin toss. It was necessary to block-randomise to maintain 
blinding by ensuring that concurrent attendees were in the same group.  
 
Intervention 
The intervention was delivered three days per week for 12 sessions by a neurophysiotherapist 
(SRL). Each session contained 2 hours of SS (active or sham) immediately prior to 30 
minutes of TST.  
 
Somatosensory Stimulation 
Somatosensory stimulation was applied to all three nerves of the affected forearm with three 
pairs of surface electrodes (13mm Ag/AgCl Biotabs, Unomedical, UK).  Electrode positions 
for both groups were: (1) median nerve cathode at the cubital fossa perpendicular to the 
anterior joint line of the elbow, anode at the midpoint of the anterior joint line of the wrist 
proximal to the carpal tunnel; (2) radial nerve cathode anterior to the lateral epicondyle of the 
elbow, anode at the lateral border of the radius proximal to the anatomical snuff box; (3) 
ulnar nerve cathode at the medial epicondylar groove of the elbow, anode distal to the medial 
border of the ulna proximal to the pisiform bone.  
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The stimulator (Electro muscle stimulator HX K11, Harox Technologies, Serbia) delivered 
bursts of 10 Hz stimulation at 50% duty cycle (500 ms on and off). For active stimulation, 
intensities were set at 3× sensory threshold (assessed for each nerve independently) to induce 
sensory paraesthesia without overt muscle contraction, and adjusted if required. Both groups 
could see a flashing light on the stimulator and a voltage indicator. The sham set up used 
severed connector leads to prevent stimulation. Participants were blinded to group allocation 
by being told that they might or might not feel the stimulation. 
 
Task Specific Training 
Both groups received standardised TST sessions which were divided into six discrete sections 
of five minutes: (1) stretching and warm up; (2) grasp; (3) grip; (4) pinch; (5) gross 
movements and (6) participant choice. The core sections (2-5) were based around tasks of the 
Action Research Arm Test (ARAT), practiced in a pseudo-randomised order. For example 
section 2 involved practice of a range of reach and grasp functional activities.  
 
Section 1 comprised slow passive sustained stretches of the upper limb held for ~30 s and 
active head/shoulder movements. For the core sections, each task was deconstructed to work 
on constituent parts as required and whole task facilitation was individually progressed. 
Movements were progressed from passive, to active-assisted, active movements with verbal 
prompting and to resisted/complex exercises once repetitive active performance was 
achieved. Resistance or complexity were increased by additional weights, increased range of 
movement, closing the eyes or standing to challenge trunk stability. All variations were 
tailored daily to the individual. 
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The ‘participant’s choice’ exercise was chosen based on agreement between the participant 
and the therapist during the first session. Participants identified a functional activity which 
was important to them and they found difficult or impossible to perform with their affected 
upper limb and a goal23 was agreed. Activities included: buttoning a shirt; carrying a cup; 
writing; self-feeding and using a light switch. These were diverse, reducing therapy 
standardisation, but reflecting therapy in clinical scenarios and improving relevance24.  
 
Assessments 
 
Participants underwent two baseline assessments, one week apart (mean 7.9 days, range 5-
20), to ensure stability. Post-intervention (P) assessments were immediately (P1; mean 2.4 
days), 3 months (P2; mean 96 days) and 6 months (P3; mean 190 days) following the 
intervention. Assessments were conducted by a trained rater (MF) who was blinded to group 
allocation. 
 
Clinical assessments included the ARAT18 and upper limb Fugl-Meyer Assessment (FM)19. 
Self-reported affected arm use was assessed with the Motor Activity Log (MAL)20. 
Corticospinal excitability and intracortical inhibition were assessed for each hemisphere 
using TMS.  
 
ARAT 
This scores upper limb function from 0–57 (high = good function)18. All tasks were attempted 
and timed using a stopwatch. Participants were allowed up to 60 s for each task and 60 s 
recorded if they were unable to complete. A total score and time (ARATtime) was calculated 
as well as times for each subsection (grasp, grip, pinch and gross). 
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MAL 
According to standardised procedures20 participants rated how much (amount of use (AOU)) 
and how well (quality of movement (QUAL)) they used their affected arm for 28 activities of 
daily living. An average score was calculated for the amount of use (MALAOU) and quality 
(MALQUAL) scales. 
 
FM 
The upper limb portion was used as a measure of impairment, scored from 0–66 (high = low 
impairment)19. 
 
Goal Attainment Scale (GAS) 
This was used in a standard manner25,26 to assess the outcome of the TST ‘participant choice’ 
activity. Weighted scores were attributed to individual goals according to task completion 
over the intervention period only.  
 
TMS 
Setup 
Participants with cerebellar lesions (active n=1, sham n=2) were not included. Motor evoked 
potentials (MEPs) from ipsilesional (affected) and contralesional primary motor cortices 
(M1) were elicited using a flat figure-of-eight coil (70 mm diameter) with a pair of Magstim 
2002 stimulators connected through a BiStim module (Magstim Company, UK). The optimal 
position for evoking MEPs in the relaxed first dorsal interosseus (FDI) muscle was 
established each session and marked directly on the scalp to ensure consistent coil placement.  
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The resting motor threshold (RMT) was determined for each FDI27 and a stimulus-response 
(SR) curve constructed from 10 stimuli at 5 intensities (90, 100, 110, 120 and 130 % RMT) in 
a random order (Signal 4.07, CED, UK). The intensities used for the first baseline were used 
for all subsequent sessions. For participants with an RMT ≥100% maximum stimulator 
output (MSO), only contralesional M1 was tested (active n=3, sham n=4). For intracortical 
inhibition (SICI), the test stimulus (TS) was set at the intensity which produced an MEP 
~50% of the participant’s maximum MEP amplitude, the conditioning stimulus (CS) at 85% 
RMT and the interstimulus interval (ISI) at 2.5ms. Ten non-conditioned and ten conditioned 
stimuli were delivered in a random order (Signal 4.07, CED, UK). 
 
MEP Analysis 
Peak-to-peak MEP amplitude (mV) was determined using Signal 4.07 (CED, UK), and 
averaged for each intensity. For SICI, the average conditioned MEP amplitude was expressed 
as a percentage of the non-conditioned then % inhibition calculated by subtracting from 100 
so that positive values indicated inhibition of the test response. 
 
The slope of the linear portion of the SR curve was calculated using a least squares method. 
Slope values were excluded if the fit resulted in an R2 value <0.85 (<2.5% of trials). The 
laterality index of linear slope was calculated using the following classic formula: 
(Slopeipsilesional – Slopecontralesional) / (Slopeipsilesional + Slopecontralesional). This yields a value 
between -1 and +1 where negative values indicate relatively reduced activity of the 
ipsilesional corticospinal pathway. 
 
Data Analysis 
The primary outcome measure was change in ARAT immediately post-intervention. 
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Following confirmation that the two baseline values were not statistically different (Paired t-
test or Wilcoxon signed rank tests) the mean was used unless otherwise stated. For between-
group comparisons change scores from baseline were calculated for ARAT, FM, MAL and 
GAS. For ARATtime % change from baseline was used. For TMS the change in laterality 
index of SR curve linear slope was calculated and positive changes indicate normalising of 
the balance in corticospinal excitability. For SICI the change in % inhibition was calculated 
for each hemisphere.  For within-group comparisons absolute scores were used for all 
assessments.  
 
The number of participants achieving a minimum clinically important change (MCID) in the 
ARAT (5.7 points) and MAL (0.5 points)28 was recorded.  
 
Statistical Analysis 
Based on a pilot study13 we estimated 34 participants (17 per group) would give 80% power 
(at 5% level) to detect a 5 point improvement in ARAT at P1.  
 
Per-protocol analysis was used. After Kolmogorov-Smirnov tests, parametric statistics were 
used for normally distributed data which are presented as mean (SD) unless otherwise 
specified. Otherwise non-parametric statistics were used and data are presented as median 
(95% confidence interval (CI)) unless otherwise specified. Significance was set at p < 0.05 or 
p < 0.017 for multiple comparisons (Bonferroni correction). 
 
Between-group 
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Independent samples t-tests or Mann Whitney U tests were used to test for differences 
between groups at baseline and for the change values at each post-intervention time-point.  
 
Within-group 
For normally distributed data, a group by time repeated measures analysis of variance 
(rmANOVA) was used. If a significant effect of time was found post-hoc pairwise 
comparisons were conducted (with Bonferroni correction). 
  
For non-normally distributed data, Friedman tests were used to examine within-group effects 
across time. If significant, post-hoc Wilcoxon signed rank tests were used to test for 
differences from baseline at each post-intervention assessment (with Bonferroni correction).  
 
MCID Analysis 
The proportion of participants reaching the MCID in ARAT (Δ > 5.7) or MAL (Δ > 0.5) was 
compared across groups using Fisher Exact tests.  
 
Regression analysis 
For the active group, post-hoc regression analysis was performed. Potential predictor 
variables (resting MEP presence, baseline SR slope laterality index, ARAT, FM, MAS, 
duration of stroke and age) were entered stepwise into multivariate linear regression analysis 
with change scores for ARAT, FM and MALAOU at each post-intervention time-point as 
dependent variables.  
 
Results 
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The intervention sessions were well attended (99.7%). Two participants (one per group) were 
lost to 3 and 6 month follow-ups (unrelated illness and Botox treatment for pre-existing 
spasticity) and one participant (sham group) failed to attend at 3 months due to unrelated 
illness, but did attend at 6 months. The sample size at each time-point is shown in Fig. 1. 
There were no serious adverse effects. Minor ones included dermatitis (n=11) at the site of 
the active SS electrodes which resolved spontaneously (n=9) or with prescribed steroid cream 
(n=2) and mild shoulder pain (sham n=2, active n=1). One participant developed short-term 
nausea and light-headedness during TMS which was discontinued (remaining in the study 
without TMS). 
 
The mean sensory threshold for the active group was 0.72 mA (range 0.71–0.74) and the 
mean stimulation intensity was 2.09 mA (range 2.05-2.15) across all 3 nerves. There were no 
significant differences between the stimulation intensities used for the three nerves (p=0.1). 
Stimulation was well tolerated. 
 
There were no differences between groups at baseline for any assessments unless specified. 
 
ARAT  
ARAT score 
ARAT scores were not normally distributed (p=0.01). There was a difference between groups 
immediately post-intervention as ARAT score increased to a greater extent for the active 
group (Δ active: 3.5 (1.5 – 8.5), sham: 1.0 (-0.5 – 5.0); p=0.031; Table. 2). There were no 
between-group differences at P2 or P3 (p> 0.4, Table 2).  
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Friedman tests revealed significant within-group changes for both groups (active: p< 0.001, 
sham: p=0.028; Table 2). Post-hoc comparisons showed improvements from baseline for the 
active group at P1 (p=0.001), P2 (p=0.014) and P3 (p=0.004). There was a non-significant 
tendency for improvement from baseline for the sham group at P1 (p=0.031), P2 (p=0.027) 
and P3 (p=0.02). 
 
The number of participants with a change score exceeding MCID was higher in the active 
group at P1 (5 vs 2) and P2 (3 vs 1). However, Fisher exact tests revealed no significant 
differences between groups at any time-point (p> 0.2). 
 
ARAT time 
ARATtime was not normally distributed (p=0.001). There was an improvement between 
baselines for the active group (B1=263.0 (192 – 467.5) s, B2=192.2 (123.0 – 440.2) s, p< 
0.05), so baseline 2 was used to calculate % change for both groups. There was no difference 
between groups at baseline 2 (p=0.26).  
 
There was a significant difference between groups for the % change in ARATtime at P1 
(p=0.017) with a greater reduction for the active group (Δ active: -27.9 (-41.8 – -10.3) %, 
sham: -9.5 (-25.7 – 0.2) %; Table 2). There were no differences at P2 or P3 (p> 0.2) 
 
For the ARAT subcomponents there was a difference between groups for the % change in 
ARATtime for grasp at P1 and pinch at P1 and P3 with the active group showing greater 
reduction (p< 0.05; Table 2). 
 
Motor Activity Log 
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Amount of Use 
Ratings were normally distributed (p=0.2). There were no differences between groups in the 
change in MALAOU at any assessment (P1: p=0.946, P2: p=0.264, P3: p=0.079; Table 2).  
 
The GROUP (active, sham) by TIME (Baseline, P1, P2, P3) rmANOVA revealed a 
significant effect of time (F2.3,63.9 = 7.679, p=0.001) but no interaction (F2.3,63.9 = 1.821, 
p=0.165). Post-hoc pairwise comparisons indicated an increase in rating from baseline for P1 
(p=0.001), P2 (p=0.003) and P3 (p=0.002). 
 
The number of participants with a change score exceeding MCID was higher in the active 
group across all assessments (P1: 7 vs 6, P2: 8 vs 4, P3: 9 vs 4). However, Fishers exact tests 
revealed no significant differences between groups at any time-point (P1: p=0.728, P2: 
p=0.264, P3: p=0.073). 
 
Quality 
Ratings were normally distributed (p=0.2). There were no differences between groups in the 
change in MALQUAL at any assessment (P1: p=0.474, P2: p=0.510, P3: p=0.375; Table 2).  
 
The GROUP (active, sham) by TIME (Baseline, P1, P2, P3) rmANOVA revealed a 
significant effect of time (F3,81 = 3.428, p=0.021) but no interaction (F3,81 = 0.834, p=0.479). 
Post-hoc pairwise comparisons indicated an increase in rating from baseline for P1 (p=0.01), 
but not P2 (p=0.17) or P3 (p=0.027). 
 
FM 
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FM scores were normally distributed (p=0.09). There were no differences between groups for 
the change at any assessment (P1: p=0.104, P2: p=0.750, P3: p=0.504; Table 2).  
 
The GROUP (active, sham) by TIME (Baseline, P1, P2, P3) rmANOVA revealed a tendency 
toward an effect of time (F1.9,,53.4 = 3.22, p=0.050) but no interaction (F1.9,53.4 = 0.82, p=0.59). 
Post-hoc pairwise comparisons showed an increase from baseline for P2 (p=0.011), but not 
P1 (p=0.021) or P3 (p=0.032). 
 
GAS 
GAS scores were not normally distributed (p< 0.001). There was a tendency for the change to 
be greater for the active group (Δ active: 20.0 (10.0 - 32.1), sham: 10.0 (0.0 – 20.0); p=0.07). 
The within-group increase was significant for both groups (active p=0.007, sham p=0.005). 
 
Transcranial Magnetic Stimulation  
RMT 
RMT was normally distributed for ipsilesional M1 (p=0.055) but not contralesional (p=0.026) 
so non-parametric statistics were used for both hemispheres. Ipsilesional M1 had a higher 
RMT than contralesional for both groups (ipsilesional active: 69 (49 - 96), sham: 77.5 (56.5 - 
100); contralesional active: 50.25 (45 - 67.5), sham: 57 (44 - 69); active p=0.008, sham 
p=0.009). There were no between-group differences at any post-intervention time-point (all 
p> 0.2) and no within-group effects for either hemisphere (all p> 0.4). 
 
Laterality Index of SR Curve linear slope 
Laterality indices were not normally distributed (p=0.008). Baseline laterality index for active 
was -0.64 (-0.98 - -0.34) and -0.88 (-1 - -0.17) for sham. There were no differences between 
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groups for the change in laterality index at any post-intervention time-point (P1: p=0.076, P2: 
p=0.603, P3: p=0.756, Fig 2A) and no within-group effects (active p=0.284, sham p=0.753).  
 
SICI 
The % inhibition was normally distributed for ipsilesional hemisphere (p=0.2) but not 
contralesional (p=0.018) so non-parametric statistics were used for both. 
 
Ipsilesional Hemisphere 
There was a significant increase in % inhibition between baselines for the active group (B1 = 
12.4 (-10.0 – 66.1) %, B2 = 40.5 (13.7 – 77.3) %; p< 0.021) so baseline 2 was used. There 
was no difference between groups at baseline 2 (p=0.724).  
 
There was a tendency toward a significant between-group difference for the change in % 
inhibition at P2 which tended to reduce to a greater extent for the active group (Δ active = -
64.4 (-92.0 – -1.2), sham = -10.4 (-46.2 – 79.8); p=0.056, Fig 2B).  There were no between-
group differences at P1 (p=0.211) or P3 (p=0.792).  
 
Friedman tests indicated a significant within-group effect for active (p=0.045), but not sham 
(p=0.564). Post-hoc comparisons for the active group showed that % inhibition was 
significantly reduced at P2 compared with baseline (p=0.013) but not at P1 (p=0.091) or P3 
(p=0.074).  However at P2 it was noted that 6 participants (of 10) in the active group showed 
facilitation of the test response, rather than inhibition. 
 
Contralesional Hemisphere 
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There were no differences between groups in the change in % inhibition at any assessment 
(p> 0.3, Fig. 2C) and no within-group effects (p> 0.08).  
 
Regression analysis 
Baseline FM predicted 30% of the variability in change in ARAT score at P1 (F1,11 = 5.8, p< 
0.05). There were no other significant predictors of change in ARAT, FM or MALAOU 
following SS. 
 
Discussion 
Four weeks of combined SS and TST induced short-term improvements in ARAT that were 
greater than after TST alone. Despite the intensive nature of the study, adherence and follow-
up rates were good. Both groups achieved their goals and increased self-reported amount of 
paretic arm use. However, these functional changes were not accompanied by significant 
modulations of corticospinal excitability.  
 
Functional Improvements 
SS combined with TST elicited greater improvements in function immediately post-
intervention than TST alone. However this was a short term effect with differences between 
groups not persisting at three or six months. The study was powered to detect a 5-point 
change in ARAT immediately post-intervention based on the information available when the 
study commenced13 and adherence to the intervention was good. However, the anticipated 
effect may have been optimistic and as such the power was lower than expected at all time-
points (P1=65, P2=16, P3=20 %). Despite this, the between-group difference at P1 was 
significant. There was also a within-group effect of time on ARAT score for both groups and 
a tendency toward an effect of time for FM, suggesting that TST was effective, but with 
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Bonferroni correction the improvements from baseline for ARAT were only significant for 
the active group, and for FM were only significant at 3 months. GAS scores improved for 
both groups suggesting that TST helped the participants to achieve their goals.  
 
Previous studies12-14 have found mixed results with regard to SS specific changes in arm 
function. McDonnell et al.13 found no between-group differences in ARAT change after 
median nerve stimulation and TST. It may be that stimulation of all three forearm nerves in 
our study provided sufficient extra input for a difference in ARAT, at least transiently. 
However, Dos Santos-Fontes et al.12 did find between-group differences in Jebsen Taylor 
Test (JTT)29 performance in a home-based study involving daily SS of the median nerve with 
training. They had more frequent sessions, suggesting that SS dosage might be a significant 
factor needing further investigation. Additionally, impairment severity was less for Dos 
Santos-Fontes (FM range 48-64) compared to this study (22-61). In our study, baseline FM 
predicted 30% of the variability in change in ARAT following combined SS and TST, 
suggesting that SS may be more effective for those who can actively use the upper limb for 
motor practice. However, baseline ARAT was not a significant predictor and further 
investigation into the factors that affect response to SS is needed. 
 
By recording the time taken to perform each ARAT task we attempted to capture any subtle 
improvements, particularly in the middle range where participants scored two out of three for 
most tasks. Consistent with ARAT score, the active group demonstrated a greater 
improvement in total time immediately post-intervention compared with sham, indicating that 
SS facilitated faster movement as well as overall score. This supports previous findings of 
improved time to perform tasks of the JTT following SS and training12. Further analysis of 
time for the subcomponents showed that SS enhanced speed particularly for dextrous 
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movements, which may be explained by the stimulation of nerves to forearm muscles. 
Similarly, McDonnell et al.13 reported improved hand dexterity, although they did not find 
overall ARAT improvements with SS. Future work is needed to examine the validity and 
reliability of ARAT time measurement and to compare it with other time-based functional 
tests, e.g. JTT29 or Wolf Motor Function Test30. 
 
Neurophysiological Mechanisms 
The median laterality index was negative at baseline, demonstrating an imbalance in 
corticospinal excitability with relative under- and over-excitability of the ipsilesional and 
contralesional motor cortices respectively. This has been demonstrated in this population 
previously31. There were no between or within-group changes for the lateralisation of M1 
excitability, so SS and TST were not associated with changes in cortical excitability. This is 
consistent with previous work13 and post-hoc power calculations indicate that we were 
adequately powered at the immediate post-intervention assessment (91 %), although not at 
the longer-term follow ups (power < 30 %). SS may improve function through mechanisms 
not assessed here, such as changes in motor programming. The lack of change in 
corticospinal excitability could potentially explain why the magnitude of ARAT 
improvement was less than we were expecting13 and why it did not persist. 
 
Inhibition (SICI) within the ipsilesional hemisphere was reduced 3 months following active 
SS.  A decrease in SICI following a single session of SS has been shown10, but to our 
knowledge this is the first study to demonstrate a longer-term effect following repeated SS 
and TST sessions. However, this must be interpreted with caution as many of the participants 
demonstrated facilitation of the test response rather than inhibition. Since we did not optimise 
the conditioning parameters for each participant it is possible that we were not specifically 
Sensory stimulation in chronic stroke 
 
20 
 
targeting the intracortical network. However it is difficult to understand why this would be 
the case at P2 only. Further investigation is required with a larger sample before conclusions 
can be drawn.  
 
Conclusions 
SS combined with TST induces short term improvements in function, as measured by ARAT, 
compared with TST alone. However, the mechanisms underlying the effect of SS remain 
unknown. 
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Figure Captions. 
Fig. 1. Trial profile 
 
Fig 2. Box and whisker plot showing change in TMS measures (with outliers removed). A. 
Stimulus Response (SR) Curve lateralisation index. Positive changes indicate improved 
balance in excitability between hemispheres. B. % inhibition of ipsilesional primary motor 
cortex (M1). Negative values indicate reduction in short latency intracortical inhibition 
(SICI). There was a significant within group effect of time for the active group and SICI was 
lower at P2 than baseline (p = 0.013). C. % inhibition of contralesional M1. Positive values 
indicate increased SICI. 
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Tables 
Table 1. Participant Characteristics. 
     Active (n=16)  Sham (n=17)    p 
Demographics 
 Age, years   62.3 (35 – 82)  60.6 (24 – 84)  0.74a 
 Gender, male   13 (81.3)       7 (41.1)     - 
Clinical Characteristics 
 Time since stroke, months 28.9 (3 – 130)  26.6 (4 – 126)  0.87b 
 Affected arm, right      10 (62.5)       9 (52.9)     -  
 Ischaemic       13 (81.2)      14 (82.4)     - 
 Haemorrhage        3 (18.8)       3 (17.6) 
Region 
Lacunar       10 (62.5)       7 (41.1)     - 
 MCA territory        4 (25.0)       7 (41.1)     - 
 Cerebellar        1 (6.3)       2 (11.8)      - 
 Unknown region       1 (6.3)       1 (5.9)     - 
Stroke disability 
 ARAT (max 57)  32.8 (10 – 43)  26.6 (9 – 49)   0.22b 
 FM (max 66)   43.3 (22 – 60)  37.5 (23 – 59)   0.08a 
 Barthel Index (max 20) 18.3 (14 – 20)  18.1 (15 – 20)   0.56b 
 FAST (max 30)    24.8 (9 – 29)  24.4 (13 – 30)  0.95b 
 MAS       1.3 (0 – 3)      1.3 (0 – 3)  0.96b 
Data are mean (range) or number (%). a Independent samples t-test, b Mann Whitney U tests between groups for 
baseline values. MCA = Middle Cerebral Artery, ARAT = Action Research Arm Test, FM = Fugl Meyer Upper Limb 
Assessment, FAST = Frenchay Aphasia Screening Test, MAS = Modified Ashworth Scale. There were no significant 
differences between groups at baseline for clinical characteristics or disability. 
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Table 2. Change from baseline 
       Active       Sham 
               P1             P2                  P3           P1                P2                             P3 
Δ ARAT Score      
Median (95 % CI)    3.5 (1.5 – 8.5)*†              2.5 (0.5 – 5.5)†               2.5 (1.5 – 5.5)†               1.0 (-0.5 – 5.0)            2.0 (0.5 – 4.0)             2.75 (0.0 – 4.5) 
% Δ ARATTime  
Median (95 % CI) 
Grasp   -28.4 (-38.0 - -20.5)*     -23.2 (-35.9 - -11.5)         -29.1 (-44.0 - -5.0)           -2.2 (-26.6 – 0.0)       -14.5 (-28.5 – 0.0)       -11.9 (-41.8 - 0.0) 
Grip   -27.8 (-40.6 - -11.9)          -10.7 (-36.2 – 1.1)         -23.7 (-32.4 - -0.8)          -3.7 (-23.4 – 0.0)        -19.9 (-22.7 – 0.0)        11.1 (-22.8 – 0.0) 
Pinch     -25.4 (-55.5 - -7.3) *       -11.2 (-37.4 – 2.8)      -29.0 (-52.4 - -13.5)*          0.0 (-30.7 – 0.0)            0.0 (-32.9 – 0.0)        -7.2 (-32.2 – 0.0) 
Gross   -18.4 (-64.7 - -0.61)          -21.0 (-37.3 – 2.0)       -21.1 (-49.7 – 10.2)           -9.6 (-35.7 – 0.9)       -19.2 (-46.3 – 0.5)       -19.6 (-42.4 – 0.6) 
 Total   -27.9 (-41.8 - -10.3)*          -8.5 (-35.5 – 7.5)         -21.2 (-38.0 - -2.9)          -9.5 (-25.7 – 3.0)       -8.9 (-29.0 – 0.09)         11.1 (-28.7 – 0.0) 
Δ MAL Rating 
Mean (SD)  
 Amount of Use‡        0.48 (0.64)                    0.54 (0.76)                    0.69 (0.93)                     0.46 (0.62)         0.26 (0.58)                0.21 (0.50) 
 Quality‡         0.29 (0.56)                     0.20 (0.66)                  0.45 (0.75)            0.17 (0.30)        0.11 (0.47)             0.10 (0.63) 
Δ FM Score 
Mean (SD)           2.5 (3.1)                   2.5 (4.2)               2.8 (4.7)         0.6 (3.6)               2.0 (4.9)            1.4 (6.8) 
CI = confidence interval. SD = standard deviation. * Significant difference between groups, p < 0.05 (Mann Whitney U test or independent samples t-test). †Difference from 
baseline (Wilcoxon Signed rank test) p < 0.017. ‡ significant effect of time (repeated measures analysis of variance). P 1 = immediate post-intervention, P2 = 3 month follow 
up, P3 = 6 month follow up assessment. Δ = change, ARAT = Action Research Arm Test, MAL = Motor Activity Log, FM = Fugl-Meyer Upper Limb Assessment.  
